GSA Capital Partners LLP Buys Shares of 65,048 Privia Health Group, Inc. $PRVA

GSA Capital Partners LLP acquired a new stake in Privia Health Group, Inc. (NASDAQ:PRVA) during the second quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor acquired 65,048 shares of the company’s stock, valued at approximately $1,674,000.

Other hedge funds also recently bought and sold shares of the company. ArrowMark Colorado Holdings LLC boosted its position in shares of Privia Health Group by 139.4% during the 4th quarter. ArrowMark Colorado Holdings LLC now owns 841,266 shares of the company’s stock worth $19,946,000 after purchasing an additional 489,866 shares during the period. Freestone Grove Partners LP increased its stake in Privia Health Group by 40.6% during the fourth quarter. Freestone Grove Partners LP now owns 1,213,342 shares of the company’s stock worth $28,768,000 after purchasing an additional 350,194 shares during the period. Renaissance Group LLC acquired a new stake in shares of Privia Health Group during the fourth quarter worth about $7,776,000. Qube Research & Technologies Ltd grew its holdings in shares of Privia Health Group by 93.3% in the second quarter. Qube Research & Technologies Ltd now owns 609,278 shares of the company’s stock valued at $14,013,000 after purchasing an additional 294,101 shares in the last quarter. Finally, Cubist Systematic Strategies LLC purchased a new stake in Privia Health Group during the 2nd quarter worth approximately $6,219,000. Hedge funds and other institutional investors own 94.48% of the company’s stock.

Wall Street Analyst Weigh In

Several brokerages have commented on PRVA. Citigroup reissued a “buy” rating on shares of Privia Health Group in a research report on Thursday, July 23rd. Weiss Ratings raised Privia Health Group from a “hold (c-)” rating to a “hold (c)” rating in a research note on Thursday, July 2nd. Barclays decreased their price objective on Privia Health Group from $25.00 to $24.00 and set an “equal weight” rating for the company in a research note on Tuesday, May 26th. Zacks Research upgraded shares of Privia Health Group from a “strong sell” rating to a “hold” rating in a report on Wednesday, August 5th. Finally, Canaccord Genuity Group set a $32.00 target price on Privia Health Group in a research note on Friday, August 7th. Eleven research analysts have rated the stock with a Buy rating and three have issued a Hold rating to the company’s stock. According to data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and a consensus target price of $31.00.

Insiders Place Their Bets

In other news, CFO David Mountcastle sold 24,734 shares of Privia Health Group stock in a transaction on Thursday, July 2nd. The stock was sold at an average price of $27.50, for a total transaction of $680,185.00. Following the completion of the transaction, the chief financial officer owned 186,728 shares of the company’s stock, valued at $5,135,020. The trade was a 11.70% decrease in their position. The transaction was disclosed in a filing with the SEC, which is available through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director Matthew Shawn Morris sold 88,110 shares of Privia Health Group stock in a transaction that occurred on Friday, June 26th. The stock was sold at an average price of $25.33, for a total value of $2,231,826.30. Following the transaction, the director owned 76,651 shares of the company’s stock, valued at $1,941,569.83. This represents a 53.48% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders have sold 327,886 shares of company stock worth $8,628,256 in the last ninety days. 5.70% of the stock is currently owned by corporate insiders.

Privia Health Group Price Performance

Shares of NASDAQ:PRVA opened at $22.00 on Monday. The firm’s 50-day simple moving average is $24.71 and its 200-day simple moving average is $23.28. Privia Health Group, Inc. has a fifty-two week low of $19.53 and a fifty-two week high of $28.82. The company has a market cap of $2.81 billion, a price-to-earnings ratio of 104.77, a PEG ratio of 1.77 and a beta of 0.85.

Privia Health Group Profile

Privia Health Group (NASDAQ: PRVA) is a physician enablement company that partners with independent physicians, medical groups and health systems to transform the delivery of patient care. Through a clinically integrated network and a proprietary technology platform, the company supports providers in managing population health, delivering coordinated care and optimizing financial performance under both fee-for-service and value-based reimbursement models.

Founded in 2016 and headquartered in McLean, Virginia, Privia Health has rapidly expanded its footprint to serve multiple metropolitan markets across the United States.